Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Entrepreneur Snehaashish Pathakk Hails Central Government’s Sporting Vision Behind India’s 85-Medal Asian Games Haul Lifestyle
  • Tulip Group Joins Forces with Schell to Revolutionize Water Efficiency in Real Estate Business
  • Yusuf Pathan inaugurates the 38th center of Cricket Academy of Pathans (CAP) in Dibrugarh (Assam) Sports
  • Assam Rifles Signs MoU with Axis Bank and NIEDO for Supporting Underprivileged Students in North East Business
  • Blurred Lines – Foram Shah’s Dark Romantic Thriller Redefines Love and Survival Lifestyle
  • Amit Puri CL Infratech: Redefining Luxury Living Amidst Nature with Vana and Vanamrit in Jim Corbett Business
  • Exclusive Interview with Advocate Anik: Shedding Light on Cyber Crime, Victim Rights, and the Path from Filing a Complaint to Recovering Funds National
  • The Role of Homeopathy in Integrated Medicine Business

Chandan Healthcare Sharpens Focus on High-Margin Diagnostics Business Through Strategic Divestment

Posted on August 8, 2026 By

Lucknow (Uttar Pradesh) [India], August 8: Chandan Healthcare Limited (NSE – CHANDAN), one of the leading diagnostic and healthcare services providers, has announced the strategic divestment of its entire shareholding in Chandan Pharmacy Limited (“CPL”), reinforcing its focus on scaling its core, higher-margin diagnostics business.

The divestment aligns with Chandan Healthcare’s strategy to sharpen its focus on the higher-margin diagnostics business. The transaction will simplify the business structure and enable greater management and capital allocation towards expanding the Company’s core diagnostics operations.

Key Strategic Benefits

  • Improved Margin Profile: Deconsolidation of the lower-margin pharmacy business is expected to improve the overall business mix and enable the stronger profitability of diagnostics to reflect more clearly in the Company’s consolidated financial performance.
  • Sharper Focus on Core Diagnostics: Greater management bandwidth and resources can be directed towards expanding the diagnostics network, increasing capacity utilisation and scaling the Company’s core operations.
  • Capital Redeployment Towards Higher-Return Assets: Proceeds from the divestment are proposed to be deployed towards the development of new diagnostic centres and capacity expansion. This will enable the Company to reallocate capital from a lower-margin business towards higher-EBITDA opportunities.
  • Simplified Business Structure: A more focused diagnostics-led structure is expected to provide greater visibility into the scale, growth and profitability of the core business while enabling more relevant benchmarking with diagnostics-focused peers.

Transaction Details

The Board has approved the divestment of Chandan Healthcare’s entire 53.56% stake in Chandan Pharmacy Limited to Chandan Hospital Limited for a consideration of approximately ₹16.77 crore. The consideration is based on CPL’s independently determined total valuation of approximately ₹31.31 crore, following which CPL will cease to be a subsidiary of the Company.

Building a Focused Diagnostics Platform

Going forward, Chandan Healthcare intends to deploy greater financial and managerial resources towards expanding its diagnostics footprint, adding new centres, strengthening capacity and driving higher utilisation across its network.

The strategic realignment is expected to result in a simpler and more focused business structure, with a stronger margin profile and future growth increasingly driven by the scale-up of the Company’s core diagnostics operations.

About Chandan Healthcare Limited

Chandan Healthcare Limited, established in 2003, is one of India’s leading providers of diagnostic and pharmacy services and a key entity of the Chandan Group. The Company delivers a comprehensive range of pathology and radiology services through its expanding network across India.

As on June 30, 2026, the Company operates 327 diagnostic centres including 264 operational franchise centres, strengthening its presence across urban, semi-urban and emerging markets. Its diagnostic portfolio comprises more than 3,000 pathology tests and 500+ radiology tests, including blood tests, X-ray, ECG, Ultrasound, CT scan, MRI and several other specialized diagnostic investigations. The Company’s network includes NABL and NABH accredited pathology laboratories and radiology centres, reflecting its commitment to delivering reliable, high-quality diagnostic services.

Chandan Healthcare operates through a diversified business model comprising B2C (Retail Customers), B2B (Institutional & Corporate Clients) and B2G (Government PPP Contracts), providing a balanced and scalable revenue profile while catering to a wide spectrum of healthcare needs.

The Company was listed on the NSE Emerge platform on February 17, 2025. 

During FY26, the Company reported Total Income of ₹280.67 Cr, EBITDA of ₹56.84 Cr and Profit After Tax (PAT) of ₹27.06 Cr, reflecting its continued operational growth and financial strength.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Business Tags:Business

Post navigation

Previous Post: Intense Technologies Reports Q1 FY27 Results; Strengthens Growth with New Client Wins, AI-led Innovation and Global Expansion
Next Post: Paul Merchants Gets RBI Approval for Perpetual AD Category-II Licence Under Revised FEMA Framework

Related Posts

  • India’s Best SEO Company Giving Best Offers on SEO Services – Zordo Technologies Business
  • Agarwal Industrial Corporation Limited shines again, reports 277% Growth in PAT in Q1FY22 (YOY) Business
  • Inspired By the Use of Agile In Enterprises, Mr. Satyavrat Nirala Creates the Agile Education Manifesto to Transform the Education Sector Business
  • Hoppup debuts in Wireless Headphones in India with the launch of Sonic Business
  • Forget Prompts: ve.ai Reads the Signal of Your Intent to Write the Future Business
  • Star Housing Finance Limited Raises $2.7 mn Equity through the Initiative of Mr. Kamlesh Shah, to augment net worth and scale up in rural geographies Business

Recent Posts

  • Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations
  • ‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27
  • The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India
  • ‘Mere Mahavir 3.1 – Mahavir Nirvana Katha’ Concludes on a Grand Spiritual Note at Bharat Mandapam
  • HydraSure’s Gen Z Team Turns GTA VI Launch Day Into a Giveaway – Planned and Live in 24 Hours

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • U2 Challengers wins CAIT YE Cricket Carnival 2023 Business
  • Top Orthopedic Experts sharing Opinion on Sports Injury Management & Recent Advances Lifestyle
  • Prime Minister inaugurates and lays foundation stones for projects worth over Rs 35,000 crore; highlights AI, skills, and Vadodara’s evolution as an industrial hub National
  • Cyble Expands Presence in ANZ Region through Partnership with Capella Consulting Business
  • Moti Jewels Palace All Set For New Year Vibe With A Glittering New Collection Lifestyle
  • Acclaimed Actress Shanthi Priya Unveils Shadow of the Serpent Fort by Author Arti Chavan at Grand Mumbai Launch event held at Title Waves Lifestyle
  • NVIDIA’s AI Crown Faces Challengers, Not A Collapse Technology
  • LANXESS Q1 sales up 43.7 percent to EUR 2.432 billion Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme